The Board of GSK has announced that Brian McNamara, the CEO of GSK Consumer Healthcare (a Joint Venture between GSK and Pfizer) has been appointed as CEO Designate of the new, listed Consumer Healthcare company which will result from the proposed demerger of Consumer Healthcare from GSK in 2022. Sir Jonathan Symonds, GSK Chairman, said,…
GlaxoSmithKline plc has reached an agreement with Pfizer Inc to combine their consumer health businesses into a new world-leading Joint Venture, with combined sales of approximately £9.8 billion ($12.7 billion). The JV will operate globally under the GSK Consumer Healthcare name. Under the terms of the transaction, GSK will have a majority controlling equity interest…